How to translate text using browser tools
1 September 2012 Biocompatibility of Antimicrobials to Maggot Debridement Therapy: Medical Maggots Lucilia sericata (Diptera: Calliphoridae) Exhibit Tolerance to Clinical Maximum Doses of Antimicrobials
George W. Peck, Benjamin C. Kirkup
Author Affiliations +
Abstract

The larvae of calliphorid flies are used to debride wounds of patients with severe tissue destruction, often concurrently with antimicrobials. The current study evaluates the effects of ceftazidime, tobramycin, amikacin, gentamicin, polymyxin B, doxycycline, paromomycin, amphotericin B, sodium stibogluconate, and miltefosine at 1,10, and 100× the Maximum Clinical Concentration (mg/kg/d) in raw liver assays. Effects on larvae were small and depended on dose and antimicrobial formulation, with hours in assay (24 or 48 h) having a significant effect on larval survival. Sodium stibgluconate had the strongest effect on maggot survival (80.0% at 48 h). These results suggest that the antimicrobials tested here may be used simultaneously with maggot debridement therapy, and may actually increase the effectiveness of maggot debridement therapy in certain applications where >1 × Maximum Clinical Concentration is indicated, such as topical creams for cutaneous leishmaniasis.

© 2012 Entomological Society of America
George W. Peck and Benjamin C. Kirkup "Biocompatibility of Antimicrobials to Maggot Debridement Therapy: Medical Maggots Lucilia sericata (Diptera: Calliphoridae) Exhibit Tolerance to Clinical Maximum Doses of Antimicrobials," Journal of Medical Entomology 49(5), 1137-1143, (1 September 2012). https://doi.org/10.1603/ME12066
Received: 21 March 2012; Accepted: 1 July 2012; Published: 1 September 2012
JOURNAL ARTICLE
7 PAGES

This article is only available to subscribers.
It is not available for individual sale.
+ SAVE TO MY LIBRARY

KEYWORDS
antibacterial
antifungal
antileishmanial
Lucilia sericata
maggot therapy
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top